Pharmaceutical PV DIV - FSB
Ended Awarded Last action
- Contract number
- SPE2DU26FT381
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,044
Award facts
- Contract value 100% obligated
- $11,043.84 Current and potential, with all options
- Completion date
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a delivery order valued at $11,043.84 from the Defense Logistics Agency (DLA) on January 13, 2026. The contract is a firm fixed-price delivery order with an ultimate completion date of January 13, 2026 and carries no set-aside designation, indicating it was awarded through full and open competition. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at up to $999,999,999.00 and runs through December 2026. This prime indefinite delivery vehicle provides comprehensive pharmaceutical support globally, enabling the company to supply a vast range of pharmaceutical products and medical supplies including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains to support military healthcare programs.
AmerisourceBergen Drug Corp operates as a subsidiary of Cencora, Inc. (doing business as AmerisourceBergen), which serves as the parent organization and holds the master indefinite delivery contracts with federal agencies including the DLA. The company's role as a critical vendor in the federal medical procurement supply chain reflects its capability to fulfill government contracts efficiently for essential pharmaceutical and medical commodities required by military treatment facilities, veterans' healthcare programs, and other federal medical institutions. The DLA Medical Supply Chain continues to leverage AmerisourceBergen's extensive pharmaceutical portfolio to meet the diverse healthcare needs of the Department of Defense and related federal health systems.
Quick answers
Who was awarded contract SPE2DU26FT381?
SPE2DU26FT381 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 13, 2026.
How much is contract SPE2DU26FT381 worth?
The government has obligated $11,044 on SPE2DU26FT381.
Is contract SPE2DU26FT381 an order under another contract?
Yes. SPE2DU26FT381 is a delivery order under SPE2DU25D4314, an indefinite delivery contract.
Was contract SPE2DU26FT381 competed?
The extent of competition for SPE2DU26FT381 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award